All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Breast Cancer: Targets and Therapy

ISSN Print: 1179-1314

ISSN Online:

Website: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal

Share:




Go

Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefit

Howard-McNatt MM

Serum calcium levels, TRPM7, TRPC1, microcalcifications, and breast cancer using breast imaging reporting and data system scores

Mandavilli S, Singh BB, Sahmoun AE

Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefit

Howard-McNatt MM

Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance

Yamamoto D, Tanaka K, Tsubota Y, Sueoka N, Shoji T, Kuwana K, Kwon AH

New developments in the treatment of HER2-positive breast cancer

Nahta R

Retraction

Singhai R

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer

Bauer M, Bryce J, Hadji P

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Geuna E, Montemurro F, Aglietta M, Valabrega G

Corrigendum

Menis J, Twelves C

Keeping an open mind: highlights and controversies of the breast cancer stem cell theory

Shah M, Allegrucci C

Decreased risk of breast cancer associated with oral bisphosphonate therapy

Mathew A, Brufsky A

A triple negative breast cancer: what it is not!

Katakkar SB

Targeting γ-secretase in breast cancer

Han J, Shen Q

Dormancy in breast cancer

Banys M, Hartkopf AD, Krawczyk N, Kaiser T, Meier-Stiegen F, Fehm T, Neubauer H

Sonomammographic characteristics of invasive lobular carcinoma

Kombar OR, Fahmy DM, Brown MV, Farouk O, El-Damshety O

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer

Hurvitz SA, Kakkar R

Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature

Kyrgias G, Theodorou K, Zygogianni A, Tsanadis K, Zervoudis S, Tzitzikas, Koukourakis M

Role of pertuzumab in the treatment of HER2-positive breast cancer

Hubalek M, Brantner C, Marth C

Wortmannin induces MCF-7 breast cancer cell death via the apoptotic pathway, involving chromatin condensation, generation of reactive oxygen species, and membrane blebbing

Akter R, Hossain MZ, Kleve MG, Gealt MA

Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective

Machado M, Einarson TR

Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles

Denewer A, Shahatto F, Elnahas W, Farouk O, Roshdy S, Khater A, Hussein O, Teima S, Hafez M, Zidan S, Shams N, Kotb S

Potential clinical applications of halichondrins in breast cancer and other neoplasms

Ortega V, Cortes J

Implications for breast cancer dormancy in other areas of medicine

Rameshwar P

Psychiatric morbidity among Egyptian breast cancer patients and their partners and its impact on surgical decision-making

El-Hadidy MA, Elnahas W, Hegazy MAF, Hafez MT, Refky B, Abdel Wahab KM

Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy

Abramson RG, Arlinghaus LR, Weis JA, Li X, Dula AN, Chekmenev EY, Smith SA, Miga MI, Abramson VG, Yankeelov TE

Serum calcium levels, TRPM7, TRPC1, microcalcifications, and breast cancer using breast imaging reporting and data system scores

Mandavilli S,Singh BB,Sahmoun AE

New developments in the treatment of HER2-positive breast cancer

Nahta R

Role of pertuzumab in the treatment of HER2-positive breast cancer

Hubalek M,Brantner C,Marth C

Sonomammographic characteristics of invasive lobular carcinoma

Kombar OR,Fahmy DM,Brown MV,Farouk O

Keeping an open mind: highlights and controversies of the breast cancer stem cell theory

Shah M,Allegrucci C

Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles

Denewer A,Shahatto F,Elnahas W,Farouk O

A triple negative breast cancer: what it is not!

Katakkar SB

Retraction

Singhai R

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer

Hurvitz SA,Kakkar R

Decreased risk of breast cancer associated with oral bisphosphonate therapy

Mathew A,Brufsky A

Targeting γ-secretase in breast cancer

Han J,Shen Q

Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance

Yamamoto D,Tanaka K,Tsubota Y,Sueoka N

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Geuna E,Montemurro F,Aglietta M,Valabrega G

Psychiatric morbidity among Egyptian breast cancer patients and their partners and its impact on surgical decision-making

El-Hadidy MA,Elnahas W,Hegazy MAF,Hafez MT

Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective

Machado M,Einarson TR

Potential clinical applications of halichondrins in breast cancer and other neoplasms

Ortega V,Cortes J

Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature

Kyrgias G,Theodorou K,Zygogianni A,Tsanadis K

Wortmannin induces MCF-7 breast cancer cell death via the apoptotic pathway, involving chromatin condensation, generation of reactive oxygen species, and membrane blebbing

Akter R,Hossain MZ,Kleve MG,Gealt MA

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer

Bauer M,Bryce J,Hadji P

Implications for breast cancer dormancy in other areas of medicine

Rameshwar P

Dormancy in breast cancer

Banys M,Hartkopf AD,Krawczyk N,Kaiser T

Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy

Abramson RG,Arlinghaus LR,Weis JA,Li X

Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer

Merriam PA, Sikov WM

Cancer biomarker HER-2/neu in breast cancer in Indian women

Singhai R, Patil VW, Patil AV

Optimal management of bone metastases in breast cancer patients

Wong MH, Pavlakis N

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705